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Abstract
Purpose To investigate the transforming
growth factor beta-induced gene (TGFBI)
mutations in Brazilian patients with corneal
dystrophy and to evaluate the phenotype–
genotype correlation in these patients.
Methods A total of 11 unrelated families
were studied. The diagnosis of corneal
dystrophy was based on clinical and
histopathological findings. Genomic DNA was
extracted from peripheral blood leucocytes,
and exons 4 and 12 of the TGFBI gene were
amplified by polymerase chain reaction
followed by direct sequencing on both
strands.
Results Five different mutations in the
TGFBI gene were found in the probands. We
identified the following mutations: lattice
corneal dystrophyFR124C and A546T; Reis-
Bu¨cklers corneal dystrophyFR555Q and
R124L; granular corneal dystrophyFR555W
and Avellino dystrophyFR555W. In three of
the 11 studied families there was no mutation
in exons 4 and 12.
Conclusions This is the first report of
mutations in the TGFBI gene in a series of
Brazilian patients with corneal dystrophy. The
findings indicate that TGFBI gene screening
should be considered in the diagnosis of
corneal dystrophy.
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Introduction
Corneal dystrophies are inherited disorders
characterized by bilateral, symmetrical
opacities. The corneal opacities are caused by
progressive accumulation of deposits resulting
in loss of transparency and visual
deterioration.1,2
Recent molecular analysis showed that
different types of corneal dystrophies are
caused by mutations in the transforming
growth factor beta-induced gene (TGFBI),
located on chromosome 5q31.2–4 Several
phenotypes are caused by specific mutations in
the TGFBI gene such as: lattice corneal
dystrophy type I (CDL1, OMIM122200), lattice
corneal dystrophy type IIIA (LCDIIIA),
granular corneal dystrophy (CDGG1, OMIM
121900), Avellino corneal dystrophy (ACD,
OMIM 121900), Reis-Bu¨cklers’s corneal
dystrophy (CDRB, OMIM 121900), and
Thiel-Behnke corneal dystrophy (CDB2,
OMIM 602082).1,4,5
Keratoepithelin, the protein product of the
TGFBI gene, is an extracellular matrix protein
expressed in many tissues including corneal
epithelium.4,6 Most patients have mutations at
mutational hot spots, corresponding to arginine
124 and 555 of the keratoepithelin protein.5,6
The diagnosis of corneal dystrophy is usually
based on the clinical findings and the
histopathological characteristics of the corneal
deposits. The genotypic approach contributes to
the assessment and refinement of the diagnosis
of corneal dystrophies particularly in the
atypical cases.2,4,5
Mutations in the TGFBI gene have been
described in patients from many nationalities.7–12
We report the first series of Brazilian patients
screened for mutations in the TGFBI gene.
Materials and methods
This study was approved by the ethics
committee of the Federal University of Sa˜o
Paulo and conformed to the tenets of the
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Declaration of Helsinki. Informed consent from all
participants was obtained for clinical and molecular
genetic study. In all, 11 unrelated families with corneal
dystrophy were studied, including patients with clinical
diagnosis of lattice dystrophy type I (CDL1),
Reis-Bu¨cklers’s dystrophy (CDRB), granular dystrophy
(CDGG), and Avellino dystrophy (ACD). The diagnoses
were confirmed by histopathology in eight patients after
corneal transplantation.
Molecular analysis
DNA of the 11 probands was extracted from peripheral
blood using standard procedures. Genomic DNA of
exons 4 and 12 of the TGFBI gene were amplified using
appropriate forward and reverse primers.9 Each
polymerase chain reaction (PCR) was carried out in 50 ml
reaction mixture containing DNA (200 ng), primers
(0.4 mM each), MgCl2 (1.5 mM), dNTPs (0.2 mM), 1PCR
buffer and Taq DNA polymerase (0.5 U). The PCR
conditions were as follows: 10 min at 941C, followed by
35 cycles of 1 min at 941C, annealing temperature for
1 min, and 721C for 1 min, with a final extension at 721C
for 5 min. The annealing temperature was 601C for exon 4
and 551C for exon 12. The PCR products were purified
with the QIAquik PCR purification kit (Qiagen Inc., ONT,
Canada) and sequenced on both strands using a dye
terminator cycle sequencing kit (Amersahm Biosciences).
The sequencing results were compared with the
nucleotide sequence of the published TGFBI cDNA.13
Exons 11, 13, and 14 of the TGFBI gene were also
investigated on the proband of family 1, diagnosed as
lattice corneal dystrophy.
Results
In all, 45 Brazilian patients from 11 unrelated families
with corneal dystrophy have been investigated. DNA
samples from 11 probands affected with lattice corneal
dystrophy (three families), Reis-Bu¨cklers’s corneal
dystrophy (four families), granular corneal dystrophy
(three families), and Avellino dystrophy (one family)
were screened for mutations within the TGFBI gene. The
two mutational hot spots (R124 and R555) were analysed
by direct sequencing of exons 4 and 12.
There were five different mutations in the 11 studied
probands (Table 1). Sequencing analysis revealed two
different mutations in patients with lattice corneal
dystrophy (families 2 and 3). The proband of family 2
presented a base pair transition at nucleotide 417 (C-T),
which converts an arginine into cysteine at codon 124
(R124C). The proband of family 3 presented the A546T
(G-A) mutation at codon 546. There was no mutation in
the hot spots of the proband of family 1. In this case
exons 11, 13, and 14 were also investigated but no
mutations were detected.
In the cases with diagnosis of Reis-Bu¨cklers’s
dystrophy two different mutations were detected
R555Q and R124L. Three probands (families 4, 5, and 6)
presented a base pair transition at nucleotide 1711
(G-A), which converts an arginine into glutamine at
codon 555 (R555Q) and one had the R124L mutation
with a G-T transition at position 418.
In one of the three families with granular dystrophy
we found the R555W mutation (Figure 1). There was no
mutation in exons 4 and 12 in the two other families
diagnosed with granular dystrophy. The proband of
family 11 diagnosed as Avellino dystrophy presented the
R555W mutation.
Discussion
We searched for mutations in the TGFBI gene in 11
unrelated Brazilian families affected with different types
of corneal dystrophies. The sequencing analysis of both
strands of exons 4 and 12 revealed mutations in eight
families.
The lattice dystrophy cases presented two mutations,
R124C and A546T, that were previously described by
other authors.4,5,14 In family 1, there was no mutation in
exons 4 and 12 of the TGFBI gene. This family had an
Table 1 Mutations found in the 11 probands
Family Corneal dystrophy Mutation
1 Lattice dystrophy F
2 Lattice dystrophy R124C
3 Lattice dystrophy A546T
4 Reis-Bu¨cklers’s dystrophy R555Q
5 Reis-Bu¨cklers’s dystrophy R555Q
6 Reis-Bu¨cklers’s dystrophy R555Q
7 Reis-Bu¨cklers’s dystrophy R124L
8 Granular dystrophy R555W
9 Granular dystrophy F
10 Granular dystrophy F
11 Avellino dystrophy R555W
Figure 1 Partial nucleotide sequence of exon 12 of the TGFBI
gene of the proband of family 8. The sequence demonstrate a
C4T transition at codon 555 (CGG4TGG) that leads to the
substitution of arginine by tryptophan (R555W).
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unusual aspect in biomicroscopy, similar in all affected
members, with peripheral corneal neovascularization
and severe stromal opacity. The lattice diagnosis was
based on histopathologic finding of amyloid stromal
deposits in several affected members that were
submitted to corneal transplant. In this case, mutation
could be present within another exon of the TGFBI gene.
Several studies reported mutations in exons 11, 13, and
14 of the TGFBI gene in cases of lattice dystrophy.1,7,15,16
As the proband of family 1 have not shown mutation in
exons 4 and 12 we investigated exons 11, 13, and 14 but
the sequence analysis have not detected mutation. Many
reasons can explain this result. The mutation in this case
could be localized in other exon or intron of the TGFBI
gene or could be detected at another gene.16,17
The A546T mutation in the TGFBI gene that had been
detected in the proband of family 2, was previously
reported in cases of lattice dystrophy type IIIA-like that
exhibited deposits similar to those observed in LCDI.14
In four probands diagnosed with Reis-Bu¨cklers’s
corneal dystrophy, three were found to have the R555Q
mutation reported to cause Thiel-Behnke dystrophy,
whereas only one had the R124L mutation reported to
cause Reis-Bu¨cklers’s dystrophy. Molecular biology
findings had shown that most of the cases diagnosed as
Reis-Bu¨cklers’s dystrophy are actually cases of Thiel-
Behnke dystrophy. The differential diagnosis can be
made by clinical and histological features or by the
genetic findings.18,19,17 In our study, the families related
to the R555Q mutation presented an early onset of
subepithelial corneal opacities associated with recurrent
erosions suggestive of Reis-Bu¨cklers’s dystrophy.
Although the proband of family 8 with granular
dystrophy had the R555W mutation, two probands
(families 9 and 10) with characteristic biomicroscopic
findings did not present any mutation in exons 4 and 12
of the TGFBI gene. It is possible that mutation in another
exon or in introns could be associated with these cases.
The proband clinically diagnosed as Avellino corneal
dystrophy (family 11) presented a R555W mutation that
is associated with granular dystrophy. It is well known
that the initial manifestation in Avellino dystrophy
presents only granular lesions demonstrating that these
two conditions can be confused when the diagnosis is
based on the clinical aspects especially in early cases.
Our results confirm the mutation hot spots at positions
R124 and R555, as only one of the mutations identified in
this study was located at other position (A456T). In four
cases, DNA analysis altered the prior diagnosis based on
clinical findings, including three families with initial
diagnosis of Reis-Bu¨ckler’s dystrophy (families 4, 5, and
6) and one family with diagnosis of Avellino dystrophy
(family 11). These findings demonstrate that gene
analysis may be useful in cases where the clinical
features and the histopathological findings of the corneal
dystrophy may not be conclusive.
All inherited corneal dystrophies caused by mutations
in the TGFBI gene are associated with an extracellular
deposition of protein within the cornea.15,20,21
Immunohistochemical studies demonstrated that the
mutated keratoepithelin is a major component of the
corneal deposits.20–22 The keratoepithelin protein has
four internal repeat domains and most of the mutations
reported are located in the amino acid R124 or in the
fourth fascilin-like domain.
The mutations in the TGFBI gene cause a range of
different types of opacities encompassing amyloid and
nonamyloid deposits.4,6 Several mechanisms have been
implicated in the pathogenesis of the TGFBI-related
corneal dystrophies. Some authors suggest that
mutations could affect the tertiary structure of
keratoepithelin causing the protein subunits to
polymerize into different structures or that the modified
domains could impair the binding of keratoepithelin to
stromal proteins such as collagen type VI affecting the
structural characteristics of the tissue.4,6,10,15 Some studies
indicate that mutations at amino acid R124 abolish a
phosphorylation site that could affect the tertiary
structure of keratoepithelin leading to amyloid
formation.4,20,22,23
Further studies are necessary to understand the role of
keratoepithelin in normal corneal structure and function.
At the moment knowledge about genotype/phenotype
correlations and the mutation status can help with
predictions of disease progression and recurrence after
treatment.
In conclusion, this is the first report of TGFBI gene
mutation in Brazilian patients with corneal dystrophies.
Our results confirm the importance of TGFBI gene
mutation analysis in the diagnosis of corneal
dystrophies.
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